PLA2G4C anticorps (AA 286-335)
Aperçu rapide pour PLA2G4C anticorps (AA 286-335) (ABIN2885165)
Antigène
Voir toutes PLA2G4C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 286-335
-
Specificité
- PLA2G4C Antibodyantibody detects endogenous levels of PLA2G4C.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide from human PLA2G4C (aa286-335).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: Peptide-ELISA (1:10000), WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C.
-
-
- PLA2G4C (Phospholipase A2, Group IVC (Cytosolic, Calcium-Independent) (PLA2G4C))
-
Autre désignation
- PLA2G4C
-
Sujet
-
Name/Gene ID: PLA2G4C
Family: Phospholipase
Synonyms: PLA2G4C, Phospholipase A2 group IVC, CPLA2-gamma -
ID gène
- 8605
-
UniProt
- Q9UP65
-
Pathways
- Inositol Metabolic Process, VEGF Signaling
Antigène
-